Serum interleukin-10 levels and adverse events in patients with acute coronary syndrome: a systematic review and meta-analysis.

Several studies investigating the prognostic utility of interleukin-10 (IL-10) in patients with acute coronary syndrome (ACS) have provided conflicting findings. The aim of the study was to assess the existing evidence regarding association between serum IL-10 levels and adverse events.